ENTEROCALM

pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of gastrointestinal disorders and diseases; pharmaceutical and medical preparations and products for the treatment of gastrointestinal disorders and diseases; anti-inflammatory drugs; pharmaceutical and medical preparations for treatment, prevention, or alleviation of inflammatory conditions of the gastrointestinal tract; pharmaceutical and medical preparations for treatment, prevention, or alleviation of inflammatory bowel disease (IBD); pharmaceutical preparations for treatment, prevention, or alleviation of Crohn's disease and ulcerative colitis; biotechnological preparations for medical use in the nature of anti-inflammatory preparations; biological compounds for use in targeted pharmaceutical therapies for the treatment of gastrointestinal disorders and diseases; drug delivery agents in the form of rectal solution, capsules, tablets that facilitate the delivery of pharmaceutical preparations; clinical medical reagents